ProfileGDS4718 / 204162_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 76% 47% 23% 68% 56% 83% 82% 67% 33% 78% 65% 72% 82% 86% 84% 75% 65% 83% 85% 80% 71% 77% 74% 70% 85% 77% 46% 81% 70% 78% 80% 77% 30% 54% 80% 77% 86% 42% 58% 32% 67% 79% 56% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.4660676
GSM549102patient 115, normal, homogenized [OPG study]5.346647
GSM549104patient 119, normal, homogenized [OPG study]4.2301223
GSM549108patient 138, normal, homogenized [OPG study]6.6992668
GSM549119patient 077, normal, homogenized [OPG study]5.896456
GSM549133patient 032, cancer, homogenized [OPG study]8.3278683
GSM549139patient 042, cancer, homogenized [OPG study]8.1437382
GSM549099patient 107, normal, homogenized [OPG study]6.6202267
GSM549109patient 139, normal, homogenized [OPG study]4.7157333
GSM549110patient 046, normal, homogenized [OPG study]7.5993378
GSM549114patient 063, normal, homogenized [OPG study]6.4355465
GSM549122patient 082, normal, homogenized [OPG study]7.0870772
GSM549134patient 033, cancer, homogenized [OPG study]8.108382
GSM549136patient 036, cancer, homogenized [OPG study]8.6680586
GSM549140patient 044, cancer, homogenized [OPG study]8.3818384
GSM549111patient 047, normal, homogenized [OPG study]7.3349375
GSM549113patient 057, normal, homogenized [OPG study]6.4868765
GSM549132patient 031, cancer, homogenized [OPG study]8.2078383
GSM549137patient 038, cancer, homogenized [OPG study]8.4673185
GSM549142patient 047, cancer, homogenized [OPG study]7.6390180
GSM549100patient 110, normal, homogenized [OPG study]6.873371
GSM549107patient 135, normal, homogenized [OPG study]7.5621777
GSM549115patient 068, normal, homogenized [OPG study]7.3266474
GSM549116patient 072, normal, homogenized [OPG study]6.8510570
GSM549120patient 078, normal, homogenized [OPG study]8.4496385
GSM549131patient 030, cancer, homogenized [OPG study]7.6625477
GSM549118patient 074, normal, homogenized [OPG study]5.3135546
GSM549129patient 027, cancer, homogenized [OPG study]8.0294181
GSM549123patient 088, normal, homogenized [OPG study]6.9154370
GSM549124patient 006, cancer, homogenized [OPG study]7.5268778
GSM549126patient 015, cancer, homogenized [OPG study]7.8606180
GSM549128patient 025, cancer, homogenized [OPG study]7.5964377
GSM549103patient 117, normal, homogenized [OPG study]4.5947630
GSM549117patient 073, normal, homogenized [OPG study]5.6843854
GSM549138patient 041, cancer, homogenized [OPG study]7.8971680
GSM549141patient 045, cancer, homogenized [OPG study]7.6494577
GSM549130patient 028, cancer, homogenized [OPG study]8.4889286
GSM549101patient 111, normal, homogenized [OPG study]5.124242
GSM549105patient 128, normal, homogenized [OPG study]6.0269458
GSM549106patient 134, normal, homogenized [OPG study]4.5967332
GSM549112patient 048, normal, homogenized [OPG study]6.6521867
GSM549125patient 011, cancer, homogenized [OPG study]7.6806879
GSM549127patient 024, cancer, homogenized [OPG study]5.9178456
GSM549135patient 035, cancer, homogenized [OPG study]9.0576889